(Q59289760)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6146861%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

title

Controlled trial of adjuvant chemotherapy with cyclophosphamide, methotrexate, and fluorouracil for breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6146861%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6146861%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

author name string

H Bush

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6146861%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

W D George

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6146861%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

J M Howat

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6146861%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

D Crowther

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6146861%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

R A Sellwood

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6146861%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

R D Rubens

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6146861%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

J L Hayward

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6146861%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

R D Bulbrook

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6146861%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

I S Fentiman

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6146861%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

language of work or name

English

0 references

publication date

1 August 1984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6146861%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6146861%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6146861%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

307-311

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6146861%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

issue

8398

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6146861%20AND%20SRC:MED&resulttype=core&format=json

Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer

27 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992684-9

7 January 2021

1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992684-9

7 January 2021

CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY WITH MELPHALAN FOR BREAST CANCER

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992684-9

7 January 2021

Psychiatric morbidity and physical toxicity associated with adjuvant chemotherapy after mastectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992684-9

7 January 2021

Adjuvant chemotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992684-9

7 January 2021

Dose-response effect of adjuvant chemotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992684-9

7 January 2021

The importance of dose intensity in chemotherapy of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992684-9

7 January 2021

10.1016/S0140-6736(84)92684-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6146861%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference